Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 4

NCT00363116

A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroi…

The purpose of the study is to determine the safety and efficacy of two dosing regimens of daclizumab in simultaneous kidney/pancreas transplant recipients.

United States298 participantsStarted 1999-04

Treatment: Daclizumab